BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37569852)

  • 21. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.
    Dehno MN; Li Y; Weiher H; Schmidt-Wolf IGH
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
    Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
    Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine-induced killer cell efficiency in multiple myeloma via the NKG2D pathway.
    Pu J; Sharma A; Liu T; Hou J; Schmidt-Wolf IG
    Clin Transl Immunology; 2024; 13(3):e1500. PubMed ID: 38529413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cord blood CD4
    Liu A; Wang Q; Yang X; Shen S; Xu Y
    Front Biosci (Landmark Ed); 2019 Jun; 24(7):1259-1270. PubMed ID: 31136978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cord blood-derived and peripheral blood-derived cytokine-induced killer cells are sensitive to Fas-mediated apoptosis.
    Durrieu L; Dieng MM; Le Deist F; Haddad E
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1407-11. PubMed ID: 23856078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition.
    Wei F; Rong XX; Xie RY; Jia LT; Wang HY; Qin YJ; Chen L; Shen HF; Lin XL; Yang J; Yang S; Hao WC; Chen Y; Xiao SJ; Zhou HR; Lin TY; Chen YS; Sun Y; Yao KT; Xiao D
    Oncotarget; 2015 Oct; 6(33):35023-39. PubMed ID: 26418951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
    Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
    Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.
    Lv LH; Wan YL; Lin Y; Zhang W; Yang M; Li GL; Lin HM; Shang CZ; Chen YJ; Min J
    J Biol Chem; 2012 May; 287(19):15874-85. PubMed ID: 22396543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDAC-selective Inhibitor Cay10603 Has Single Anti-tumour Effect in Burkitt's Lymphoma Cells by Impeding the Cell Cycle.
    Ma XJ; Xu G; Li ZJ; Chen F; Wu D; Miao JN; Zhan Y; Fan Y
    Curr Med Sci; 2019 Apr; 39(2):228-236. PubMed ID: 31016515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].
    Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Ma L; You Q; Xiao X; Deng Q; Li YM
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):293-9. PubMed ID: 23578511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines.
    Robles AI; Wright MH; Gandhi B; Feis SS; Hanigan CL; Wiestner A; Varticovski L
    Clin Cancer Res; 2006 Nov; 12(21):6547-56. PubMed ID: 17085670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.
    Dos Santos Ferreira AC; Fernandes RA; Kwee JK; Klumb CE
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):317-25. PubMed ID: 22131152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.
    Cappuzzello E; Sommaggio R; Zanovello P; Rosato A
    Cytokine Growth Factor Rev; 2017 Aug; 36():99-105. PubMed ID: 28629761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma.
    Nwangwu CA; Weiher H; Schmidt-Wolf IGH
    Hematol Oncol; 2017 Dec; 35(4):719-725. PubMed ID: 27430430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
    Inman GJ; Allday MJ
    J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models.
    Tao L; Huang G; Shi S; Chen L
    Med Oncol; 2014 Jan; 31(1):777. PubMed ID: 24271420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
    Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.